$PG

Procter & Gamble 2026: Revenue $23.28B, Net income $4.76B, EPS $1.97— 10-Q Summary

Procter & Gamble reported 2026 revenue of $23.28B, up 4% YoY, and net income of $4.76B, down 0.5% YoY. EPS rose 1% to $1.97. The company announced a two-year restructuring plan and completed the $3.9B acquisition of Thorne.

Original reporting
Published Oct 22, 2026, 8:21 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Procter & Gamble 2026: Revenue $23.28B, Net income $4.76B, EPS $1.97— 10-Q Summary — source image
Decision brief

The 30-second read

$PGNeutralHigh
01

Why it matters

The earnings release introduces new data that could shift short‑term pricing, while the restructuring and acquisition signal longer‑term strategic moves.

02

Market read

Primary earnings disclosure for a large‑cap consumer staple; immediate relevance for traders and sector peers.

03

What to watch

The $3.9B Thorne acquisition may add growth potential not yet reflected in the quarter.

Relevance 8/10Novelty 8/10Timing: after‑hours release

Background

Procter & Gamble’s quarterly filing provides the latest financial snapshot and outlines a $2B cost‑restructuring plan and a recent acquisition.

Company-level read

Ticker impact

$PGNeutralHigh confidence
Context

Procter & Gamble filed its 10‑Q showing Q4 revenue of $23.28B, net income $4.76B and EPS $1.97, the first public disclosure of these results.

Expected impact

likely modest downside as investors weigh the slight net‑income decline against revenue growth

Evidence & confidence

The numbers are fresh, large‑cap, and deviate from consensus expectations, prompting short‑term price pressure.

Market effects

Consumer staples earnings may influence peer valuations and sector sentiment.

U.S. market outlook modestly affected; no major regional ripple.

Limited to global consumer‑goods investors; no broad macro impact.

Counterpoint

The restructuring plan and cost cuts could offset earnings weakness, supporting a longer‑term upside.

Key entities

  • Procter & Gamble

    Consumer‑goods conglomerate reporting Q4 2026 results.

  • Thorne

    Wellness and supplements brand acquired for $3.9B.

Related articles

$PGHighAI 9/10

Procter & Gamble Stocks Gain 5.62% on Volume-Led Quarter

Procter & Gamble (PG) reported a 4% sales increase to $23.3B in Q1, driven by volume growth. Shares rose 5.62% to $165.65. Earnings grew 1% to $1.97 per share, but higher costs impacted margins. Operating cash flow was $5.8B, supporting dividends and buybacks. The stock trades near its GF Value estimate.

$PGMedAI 8/10

P&G (PG) Q1 2027 Earnings Call Transcript

P&G (PG) reported Q1 2027 earnings with organic sales growth across all 10 product categories and 6 regions. North America and Europe grew 3% and 4% respectively, while Greater China saw 8% growth. Core EPS was $2, down 1 point YoY. The company maintained guidance for fiscal 2027 and highlighted successful product launches like Pantene's Abundant and Strong, Pampers Amoira, and Fairy Dish.

$PGMedAI 8/10

The Procter & Gamble Company Q1 2027 Earnings Call Summary

Procter & Gamble reported Q1 2027 organic sales growth of 4.0%, driven by volume increases and strategic interventions. Market share improved in the U.S. and China, with the latter benefiting from competitive dynamics. The company maintained fiscal 2027 guidance for 1%-3% organic sales growth, despite a $1.4 billion after-tax headwind from raw materials and energy. Management expects sequential acceleration in sales growth and plans to offset costs through productivity gains and pricing actions.

$PGHighAI 8/10

Procter & Gamble earnings analysis: questions answered and next catalysts

Procter & Gamble (PG) reported fiscal Q1 2027 earnings beating estimates with EPS of $2.00 and revenue of $23.28B. Organic sales grew 4.0%, and all categories and regions showed growth. However, margins fell due to rising commodity costs, and the company raised its cost-headwind estimate to $1.9B. The stock is trading at $166.58, near its 52-week high, with a market cap of $387B.